Tags
Results for: Brain Cancer
-
Article Item
New cancer drug shows promise in targeting genetic weakness in tumors, Virginia Tech expert says , articleIn an invited review article in Cancer Discovery, a journal of the American Association for Cancer Research, Kathleen Mulvaney, assistant professor with the Fralin Biomedical Research Institute at VTC, talks about the potential of a new drug that has shown early promise in clinical trials for solid tumors by killing cancer cells that lack specific genes.
Date: Nov 01, 2023 -
Article Item
Fralin Biomedical Research Institute spinoff Cairina Inc. translates science into improved cancer treatments , articleThe company recently received support from Virginia Tech Intellectual Properties to help commercialize better tools for surgeons and oncologists.
Date: Jul 17, 2023 -
Article Item
Children's National Hospital, Virginia Tech unite to advance AI for pediatric health , articleScientists shared their progress in building digital twins to predict surgical outcomes, enhancing visualization to increase the precision of delicate interventions, establishing data command centers to anticipate risks for fragile patients, and more.
Date: Jul 07, 2023 -
Article Item
Common challenge, different strategies: Virginia Tech Cancer Research Alliance gathers broad mix of researchers and clinicians , articleThe second annual Virginia Tech Cancer Research Alliance retreat, hosted this year on the Children’s National Research & Innovation Campus, brought together scientists and physicians on the leading edge of developing innovative therapy types, fresh biological targets, and new technologies to take on cancer.
Date: Jun 21, 2023 -
Article Item
‘We have a very rich resource here’ , articleScientist Jia-Ray Yu and collaborators tackle pediatric brain cancer in Fralin Biomedical Research Institute’s growing presence in the greater Washington, D.C., metro area.
Date: Jun 20, 2023 -
Article Item
New cancer biologist targets ‘Achilles heel’ in deadly brain cancers , articleCancer biologist Kathleen Mulvaney joins the faculty of the Fralin Biomedical Research Institute at VTC on Oct. 1. Her lab will be in Washington, D.C., on the Children’s National Research & Innovation Campus as part of a partnership between Virginia Tech and Children’s National.
Date: Sep 27, 2022 -
Article Item
Virginia Tech researcher’s 3D model of brain tumor environment could aid personalized treatment , articleScientists have developed a novel 3D tissue-engineered model of the glioblastoma tumor microenvironment that can be used to learn why the tumors return and what treatments will be most effective at eradicating them – right down to a patient-specific level.
Date: Aug 02, 2022 -
Article Item
Cancer Research Alliance forges new collaborations, strengthens research programs at inaugural retreat , articleMore than 100 cancer researchers from across Virginia Tech recently met at the first Cancer Research Alliance retreat hosted by the Fralin Biomedical Research Institute at VTC.
Date: Apr 04, 2022 -
Article Item
Rare disease research gives families hope, ‘vital’ to advancing medicine , articleRare diseases afflict 300 million people worldwide. Fralin Biomedical Research Institute at VTC researchers are bridging a gap in scientific knowledge by studying some of the diseases that together add up to a formidable public health challenge. Feb. 28 marks the 14th international Rare Disease Day.
Date: Feb 28, 2022 -
Video ItemScientists at Fralin Biomedical Research Institute develop new strategy for brain cancer treatment , video
In a new study published in Oncogenesis, Zhi Sheng and Rob Gourdie of the Fralin Biomedical Research Institute at VTC describe how two protein-targeting drugs – when combined with chemotherapy – yield synergistic cytotoxicity to treatment-resistant glioblastoma.
Date: Jan 28, 2022 -
Article Item
Fralin Biomedical Research Institute biotech spin-out raises additional $305,000 in investments , articleWith this wave of new grants and investments, Acomhal Research Inc. is nearing a million dollars in total funding toward development of a new therapeutic to fight drug-resistant cancers such as glioblastoma multiforme and metastatic disease including triple negative breast cancer.
Date: Dec 20, 2021 -
Video ItemMeet Jenny Munson, a cancer scientist at the Fralin Biomedical Research Institute , video
Jenny Munson is a principal investigator at the Fralin Biomedical Research Institute who studies the tumor microenvironment in cancers, including glioblastoma, the deadliest form of brain cancer. Munson's lab is located in the new $90-million biomedical research addition building in Roanoke.
Date: Dec 03, 2021 -
Article Item
Ivy Foundation grant aids Fralin Biomedical Research Institute scientist’s search for treatment for deadly brain cancer , articleJennifer Munson, an associate professor at the Fralin Biomedical Research Institute at VTC, an expert in interstitial fluid flow - the movement of liquid within and around living tissues - will use the $500,000 award to further her study of patient-specific therapies for deadly brain tumors.
Date: Sep 21, 2021 -
Article Item
From pasture to patient: Fralin Biomedical Research Institute scientists distill cow’s milk into nano-capsules for drug delivery , articleRob Gourdie, professor and director of the Center for Vascular and Heart Research at the Fralin Biomedical Research Institute at VTC, and his lab team developed a scalable method to harvest nano-sized biological capsules called exosomes from unpasteurized cow’s milk. Exosomes are a promising candidate for drug delivery in humans.
Date: Aug 19, 2021 -
Article Item
TBMH graduate student awarded two grants to advance brain cancer research , articleJoelle Martin, who will defend her doctoral dissertation this month, received the Zeta Beta Tau Cancer Research Award and a graduate fellowship provided by philanthropist, alumnus, and longtime Virginia Tech benefactor Ray Gaskins ‘64.
Date: May 05, 2021 -
Article Item
Scientists from Virginia Tech, City of Hope aim to improve therapy for deadly brain cancer , articleResearchers at the Fralin Biomedical Research Institute at VTC and City of Hope believe the complex way fluid flows through glioblastoma tumors holds the key to improving the success of CAR-T cell therapy in treating the cancer and helping more patients survive.
Date: Apr 28, 2021 -
Video ItemTBMH graduate student awarded two grants to advance brain cancer research , video
<div><div><div><div><div><p>Joelle Martin, a graduate research assistant in the Sontheimer Lab at the Fralin Biomedical Research Institute at VTC, received a Zeta Beta Tau Cancer Research Award and a student fellowship funded by Virginia Tech alumnus and benefactor Ray Gaskins.</p></div></div></div></div></div>
Date: Mar 11, 2021 -
Article Item
Unified Vision: How Children’s National Hospital, Virginia Tech, JLABS are creating pediatric and healthcare research hub in Washington, D.C. , articleLeaders from Children's National Hospital, Virginia Tech, and Johnson & Johnson Innovation LLC detailed how ambitious goals and strategic alignment were key to developing the new Children's National Research & Innovation Campus at last week's Healthcare Project Delivery Conference.
Date: Feb 28, 2021 -
Article Item
Of mice, men – and fish: Researchers find parallels in spread of human brain cancer cells in mammals, zebrafish , articleScientists at the Fralin Biomedical Research Institute at VTC have identified a new zebrafish model that could help advance glioblastoma multiforme research.
Date: Feb 11, 2021 -
Article Item
Virginia Tech, Children’s National Hospital award $100,000 to fund collaborative cancer research pilot projects , articleChildren’s National Hospital and Virginia Tech have awarded two $50,000 one-year pilot grants to multi-institutional teams of scientists for pediatric brain cancer research.
Date: Jan 12, 2021
Page 1 of 3 | 42 Results